1. Home
  2. CTRE vs GKOS Comparison

CTRE vs GKOS Comparison

Compare CTRE & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRE
  • GKOS
  • Stock Information
  • Founded
  • CTRE 2013
  • GKOS 1998
  • Country
  • CTRE United States
  • GKOS United States
  • Employees
  • CTRE N/A
  • GKOS N/A
  • Industry
  • CTRE Real Estate Investment Trusts
  • GKOS Medical/Dental Instruments
  • Sector
  • CTRE Real Estate
  • GKOS Health Care
  • Exchange
  • CTRE Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • CTRE 5.7B
  • GKOS 5.8B
  • IPO Year
  • CTRE N/A
  • GKOS 2015
  • Fundamental
  • Price
  • CTRE $33.01
  • GKOS $89.34
  • Analyst Decision
  • CTRE Buy
  • GKOS Strong Buy
  • Analyst Count
  • CTRE 6
  • GKOS 12
  • Target Price
  • CTRE $31.67
  • GKOS $131.17
  • AVG Volume (30 Days)
  • CTRE 1.6M
  • GKOS 1.3M
  • Earning Date
  • CTRE 08-06-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • CTRE 4.08%
  • GKOS N/A
  • EPS Growth
  • CTRE 108.23
  • GKOS N/A
  • EPS
  • CTRE 1.21
  • GKOS N/A
  • Revenue
  • CTRE $373,415,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • CTRE $16.16
  • GKOS $27.88
  • Revenue Next Year
  • CTRE $20.30
  • GKOS $27.76
  • P/E Ratio
  • CTRE $27.20
  • GKOS N/A
  • Revenue Growth
  • CTRE 50.83
  • GKOS 26.70
  • 52 Week Low
  • CTRE $24.79
  • GKOS $77.10
  • 52 Week High
  • CTRE $33.52
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • CTRE 70.19
  • GKOS 41.98
  • Support Level
  • CTRE $31.92
  • GKOS $84.37
  • Resistance Level
  • CTRE $33.52
  • GKOS $90.30
  • Average True Range (ATR)
  • CTRE 0.70
  • GKOS 3.72
  • MACD
  • CTRE 0.10
  • GKOS -0.33
  • Stochastic Oscillator
  • CTRE 82.89
  • GKOS 43.41

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: